Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate in treating poststroke depression.

V R Lingam1, L W Lazarus, L Groves

  • 1Walter P. Reuther Psychiatric Hospital, Westland, Mich. 48185.

The Journal of Clinical Psychiatry
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023.

Endocrine connections·2026
Same author

Temperature impacts Atlantic salmon's (

Fish and shellfish immunology reports·2023
Same author

Real-world treatment sequencing and survival in previously treated advanced renal cell carcinoma patients receiving nivolumab monotherapy: a UK retrospective cohort study.

BMC cancer·2022
Same author

Low speech rate but high gesture rate during conversational interaction in people with Cornelia de Lange syndrome.

Journal of intellectual disability research : JIDR·2021
Same author

Microwave Endometrial Ablation: Prospective Case Review and Patient Satisfaction Survey.

Journal of minimally invasive gynecology·2016
Same author

The Essure Hysteroscopic Sterilization: Initial Experience in Cardiff, UK - Does Prior Contraception Influence the Ease of Device Placement?

Journal of minimally invasive gynecology·2016
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Methylphenidate effectively treated poststroke depression in 52% of patients, with rapid mood improvement and minimal side effects. This suggests it is a valuable option for managing depression following a stroke.

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Poststroke depression is a common and debilitating complication following cerebrovascular accidents.
  • Effective treatment options for poststroke depression are crucial for patient recovery and quality of life.

Purpose of the Study:

  • To evaluate the efficacy and safety of methylphenidate in treating patients with poststroke depression.
  • To identify factors associated with treatment response in this patient population.

Main Methods:

  • Retrospective chart review of 25 patients diagnosed with poststroke depression.
  • Treatment with methylphenidate.
  • Analysis of demographic characteristics, stroke location, and treatment outcomes.

Main Results:

Related Experiment Videos

  • 52% of patients (13 out of 25) achieved complete remission of depressive symptoms.
  • Mood improvement was observed within 48 hours in responders.
  • Only 12% of patients (3 out of 25) experienced significant side effects.
  • No significant differences were found between responders and non-responders in demographic or stroke-related variables.

Conclusions:

  • Methylphenidate demonstrates potential as a valuable therapeutic agent for poststroke depression.
  • The rapid onset of action and favorable side effect profile support its use.
  • Further prospective studies are warranted to confirm these findings.